0001127602-18-025253.txt : 20180814 0001127602-18-025253.hdr.sgml : 20180814 20180814133429 ACCESSION NUMBER: 0001127602-18-025253 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180813 FILED AS OF DATE: 20180814 DATE AS OF CHANGE: 20180814 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith David Ross CENTRAL INDEX KEY: 0001650274 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 181016063 MAIL ADDRESS: STREET 1: 251 BALLARDVALE STREET CITY: WILMINGTON STATE: MA ZIP: 01887 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 781-222-6000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-08-13 0001100682 CHARLES RIVER LABORATORIES INTERNATIONAL INC CRL 0001650274 Smith David Ross 251 BALLARDVALE STREET WILMINGTON MA 01887 1 Corporate Executive VP & CFO Common Stock 2018-08-13 4 M 0 1249 76.12 A 13690 D Common Stock 2018-08-13 4 S 0 200 119.20 D 13490 D Common Stock 2018-08-13 4 S 0 100 119.59 D 13390 D Common Stock 2018-08-13 4 S 0 100 119.65 D 13290 D Common Stock 2018-08-13 4 S 0 100 119.82 D 13190 D Common Stock 2018-08-13 4 S 0 100 119.91 D 13090 D Common Stock 2018-08-13 4 S 0 100 120.04 D 12990 D Common Stock 2018-08-13 4 S 0 100 120.27 D 12890 D Common Stock 2018-08-13 4 S 0 149 120.35 D 12741 D Common Stock 2018-08-13 4 S 0 64 120.58 D 12677 D Common Stock 2018-08-13 4 S 0 36 120.805 D 12641 D Common Stock 2018-08-13 4 S 0 100 120.81 D 12541 D Common Stock 2018-08-13 4 S 0 100 121.01 D 12441 D Stock Options (Right to Buy) 76.12 2018-08-13 4 M 0 1249 0 D 2016-08-12 2020-08-12 Common Stock 1249 1249 D This sale occurred pursuant to a 10b5-1 Trading Plan. /s/ David R. Smith 2018-08-13